Literature DB >> 15070895

Rhodopsin activation exposes a key hydrophobic binding site for the transducin alpha-subunit C terminus.

Jay M Janz1, David L Farrens.   

Abstract

Conformational changes enable the photoreceptor rhodopsin to couple with and activate the G-protein transducin. Here we demonstrate a key interaction between these proteins occurs between the C terminus of the transducin alpha-subunit (G(Talpha)) and a hydrophobic cleft in the rhodopsin cytoplasmic face exposed during receptor activation. We mapped this interaction by labeling rhodopsin mutants with the fluorescent probe bimane and then assessed how binding of a peptide analogue of the G(Talpha) C terminus (containing a tryptophan quenching group) affected their fluorescence. From these and other assays, we conclude that the G(Talpha) C-terminal tail binds to the inner face of helix 6 in a retinal-linked manner. Further, we find that a "hydrophobic patch" comprising key residues in the exposed cleft is required for transducin binding/activation because it enhances the binding affinity for the G(Talpha) C-terminal tail, contributing up to 3 kcal/mol for this interaction. We speculate the hydrophobic interactions identified here may be important in other GPCR signaling systems, and our Trp/bimane fluorescence methodology may be generally useful for mapping sites of protein-protein interaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070895     DOI: 10.1074/jbc.M402567200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Mutations of CB1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization.

Authors:  Aaron M D'Antona; Kwang H Ahn; Debra A Kendall
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  Distinct interactions between the human adrenergic beta(2) receptor and Galpha(s)--an in silico study.

Authors:  Andrea Strasser; Hans-Joachim Wittmann
Journal:  J Mol Model       Date:  2010-01-30       Impact factor: 1.810

Review 3.  Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs.

Authors:  Chih-chin Huang; John J G Tesmer
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

4.  Short-range molecular rearrangements in ion channels detected by tryptophan quenching of bimane fluorescence.

Authors:  Leon D Islas; William N Zagotta
Journal:  J Gen Physiol       Date:  2006-09       Impact factor: 4.086

5.  A hypothesis for GPCR activation.

Authors:  Jerzy Ciarkowski; Magdalena Witt; Rafał Slusarz
Journal:  J Mol Model       Date:  2005-05-12       Impact factor: 1.810

Review 6.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

7.  Bacteriorhodopsin chimeras containing the third cytoplasmic loop of bovine rhodopsin activate transducin for GTP/GDP exchange.

Authors:  Andrew H Geiser; Michael K Sievert; Lian-Wang Guo; Jennifer E Grant; Mark P Krebs; Dimitrios Fotiadis; Andreas Engel; Arnold E Ruoho
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

8.  Conformational states and dynamics of rhodopsin in micelles and bilayers.

Authors:  Ana Karin Kusnetzow; Christian Altenbach; Wayne L Hubbell
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

Review 9.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors.

Authors:  Harel Weinstein
Journal:  AAPS J       Date:  2006-01-06       Impact factor: 4.009

10.  Two protonation switches control rhodopsin activation in membranes.

Authors:  Mohana Mahalingam; Karina Martínez-Mayorga; Michael F Brown; Reiner Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.